Probiotics: their role in the treatment and prevention of disease

References

• Isolauri E, Salminen S, Ouwehand AC. Microbial–gut interactions in health and disease. Probiotics. Best Prac. Res. Clin. Gastroenterol.18(2), 299–313 (2004).
   PubMed Web of Science ®Google Scholar
• Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell118(2), 229–241 (2004).
   PubMed Web of Science ®Google Scholar
• Ashwell M. Concise monograph on concept of functional foods. International Life Sciences Institute, Europe (2002).
   Google Scholar
• Metchnikoff E. The Prolongation of Life.Putnam’s sons, London, UK (1908).
   Google Scholar
• Gorbach SL. The discovery of Lactobacillus GG. Nutr. Today31, 25–45 (1996).
   Google Scholar
• Hudault S, Lievin V, Bernet-Camard MF, Servin AL. Antagonistic activity exerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol.63(2), 513–518 (1997).
   PubMed Web of Science ®Google Scholar
• Naaber P, Mikelsaar RH, Salminen S, Mikelsaar M. Bacterial translocation, intestinal microflora and morphological changes of intestinal mucosa in experimental models of Clostridium difficile infection. J. Med. Microbiol.47(7), 591–598 (1998).
   PubMed Web of Science ®Google Scholar
• Salminen SJ, Donohue DC. Safety assessment of Lactobacillus strain GG (ATCC 53103). Nutr. Today Suppl.31(6), 12S–15S (1995).
   Google Scholar
• Dong MY, Chang TW, Gorbach SL. Effects of feeding Lactobacillus GG on lethal irradiation in mice. Diagn. Microbiol. Infect. Dis.7(1), 1–7 (1987).
   PubMed Web of Science ®Google Scholar
• Lee DJ, Drongowski RA, Coran AG, Harmon CM. Evaluation of probiotic treatment in a neonatal animal model. Pediatr. Surg. Int.16(4), 237–242 (2000).
   PubMed Web of Science ®Google Scholar
• Chan RC, Reid G, Irvin RT, Bruce AW, Costerton JW. Competitive exclusion of uropathogens from human uroepithelial cells by Lactobacillus whole cells and cell wall fragments. Infect. Immun.47(1), 84–89 (1985).
   PubMed Web of Science ®Google Scholar
• Mack DR, Michail S, Wei S, McDougall L, Holligsworth MA. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol.276, G941–G950 (1999).
   PubMed Web of Science ®Google Scholar
• Coconnier MH, Bernet MF, Kerneis S, Chauviere G, Fourniat J, Servin AL. Inhibition of adhesion of enteroinvasive pathogens to human intestinal Caco-2 cells by Lactobacillus acidophilus strain LB decreases bacterial invasion. FEMS Microbiol. Lett.110(3), 299–305 (1993).
   PubMed Web of Science ®Google Scholar
• Wilson KH, Perini F. Role of competition for nutrients in suppression of Clostridium difficile by the colonic microflora. Infect. Immun.56(10), 2610–2614 (1988).
   PubMed Web of Science ®Google Scholar
• Fang W, Shi M, Huang L, Chen J, Wang Y. Antagonism of lactic acid bacteria towards Staphylococcus aureus and Escherichia coli on agar plates and in milk. Vet. Res.27(1), 3–12 (1996).
   PubMed Web of Science ®Google Scholar
• Lehto EM, Salminen SJ. Inhibition of Salmonella typhimurium adhesion to Caco-2 cell cultures by Lactobacillus strain GG spent culture supernate: only a pH effect? FEMS Immunol. Med. Microbiol.18(2), 125–132 (1997).
   PubMedGoogle Scholar
• Forestier C, De Champs C, Vatoux C, Joly B. Probiotic activities of Lactobacillus casei rhamnosus: in vitro adherence to intestinal cells and antimicrobial properties. Res. Microbiol.152(2), 167–173 (2001).
   PubMed Web of Science ®Google Scholar
• Gan BS, Kim J, Reid G, Cadieux P, Howard JC. Lactobacillus fermentum RC-14 inhibits Staphylococcus aureus infection of surgical implants in rats. J. Infect. Dis.185(9), 1369–1372 (2002).
   PubMed Web of Science ®Google Scholar
• Velraeds MM, van der Mei HC, Reid G, Busscher HJ. Inhibition of initial adhesion of uropathogenic Enterococcus faecalis by biosurfactants from Lactobacillus isolates. Appl. Environ. Microbiol.62(6), 1958–1963 (1996).
   PubMed Web of Science ®Google Scholar
• Servin AL. Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens. FEMS Microbiol. Rev.28(4), 405–440 (2004).
   PubMed Web of Science ®Google Scholar
• Bernet-Camard MF, Lievin V, Brassart D, Neeser JR, Servin AL, Hudault S. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol.63(7), 2747–2753 (1997).
   PubMed Web of Science ®Google Scholar
• Silva M, Jacobus NV, Deneke C, Gorbach SL. Antimicrobial substance from a human Lactobacillus strain. Antimicrob. Agents Chemother.31(8), 1231–1233 (1987).
   PubMed Web of Science ®Google Scholar
• Axelsson LT, Dobrogosz WJ, Lindgren SE. Production of a broad spectrum antimicrobial substance by Lactobacillus reuteri. Microb. Ecol. Health Dis.2, 131–136 (1989).
   Google Scholar
• Madsen K, Cornish A, Soper P et al. Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology121(3), 580–591 (2001).
   PubMed Web of Science ®Google Scholar
• Otte JM, Podolsky DK. Functional modulation of enterocytes by Gram-positive and Gram-negative microorganisms. Am. J. Physiol.Gastrointest. Liver Physiol.286(4), G613–G626 (2004).
   PubMed Web of Science ®Google Scholar
• Miettinen M, Vuopio-Varkila J, Varkila K. Production of human tumor necrosis factor alpha, interleukin-6, and interleukin-10 is induced by lactic acid bacteria. Infect. Immun.64(12), 5403–5405 (1996).
   PubMed Web of Science ®Google Scholar
• Miettinen M, Matikainen S, Vuopio-Varkila J et al. Lactobacilli and streptococci induce interleukin-12 (IL-12), IL-18, and gamma interferon production in human peripheral blood mononuclear cells. Infect. Immun.66(12), 6058–6062 (1998).
   PubMed Web of Science ®Google Scholar
• Christensen HR, Frokiaer H, Pestka JJ. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J. Immunol.168(1), 171–178 (2002).
   PubMed Web of Science ®Google Scholar
• Matsuguchi T, Takagi A, Matsuzaki T et al. Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2. Clin. Diagn. Lab. Immunol.10(2), 259–266 (2003).
   PubMedGoogle Scholar
• Braat H, de Jong EC, van den Brande JM et al. Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. J. Mol. Med.82(3), 197–205 (2004).
   PubMed Web of Science ®Google Scholar
• Bunout D, Hirsch S, Pia DLM et al. Effects of prebiotics on the immune response to vaccination in the elderly. JPEN J. Parenter. Enteral Nutr.26(6), 372–376 (2002).
   PubMed Web of Science ®Google Scholar
• Maassen CB, Holten-Neelen C, Balk F et al. Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains. Vaccine18(23), 2613–2623 (2000).
   PubMed Web of Science ®Google Scholar
• Miettinen M, Lehtonen A, Julkunen I, Matikainen S. Lactobacilli and streptococci activate NF-kappa B and STAT signaling pathways in human macrophages. J. Immunol.164(7), 3733–3740 (2000).
   PubMed Web of Science ®Google Scholar
• Rachmilewitz D, Katakura K, Karmeli F et al. Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology126(2), 520–528 (2004).
   PubMed Web of Science ®Google Scholar
• Veckman V, Miettinen M, Pirhonen J, Siren J, Matikainen S, Julkunen I. Streptococcus pyogenes and Lactobacillus rhamnosus differentially induce maturation and production of Th1-type cytokines and chemokines in human monocyte-derived dendritic cells. J. Leukoc. Biol.75(5), 764–771 (2004).
   PubMed Web of Science ®Google Scholar
• Kaila M, Isolauri E, Soppi E, Virtanen E, Laine S, Arvilommi H. Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain. Pediatr. Res.32(2), 141–144 (1992).
   PubMed Web of Science ®Google Scholar
• Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatr. Gastroenterol. Nutr.20(3), 333–338 (1995).
   PubMed Web of Science ®Google Scholar
• Kaila M, Isolauri E, Saxelin M, Arvilommi H, Vesikari T. Viable versus inactivated Lactobacillus strain GG in acute rotavirus diarrhoea. Arch. Dis. Child.72(1), 51–53 (1995).
   PubMed Web of Science ®Google Scholar
• Schultz M, Linde HJ, Lehn N et al. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J. Res.70(2), 165–173 (2003).
   Google Scholar
• Pelto L, Isolauri E, Lilius EM, Nuutila J, Salminen S. Probiotic bacteria down-regulate the milk-induced inflammatory response in milk-hypersensitive subjects but have an immunostimulatory effect in healthy subjects. Clin. Exp. Allergy28(12), 1474–1479 (1998).
   PubMed Web of Science ®Google Scholar
• Isolauri E, Majamaa H, Arvola T, Rantala I, Virtanen E, Arvilommi H. Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology105(6), 1643–1650 (1993).
   PubMed Web of Science ®Google Scholar
• Banasaz M, Norin E, Holma R, Midtvedt T. Increased enterocyte production in gnotobiotic rats mono-associated with Lactobacillus rhamnosus GG. Appl. Environ. Microbiol.68(6), 3031–3034 (2002).
   PubMed Web of Science ®Google Scholar
• O’Sullivan DJ. Probiotics: A Critical Review.Horizon Scientific Press, UK (1999).
   Google Scholar
• Boekhorst J, Siezen RJ, Zwahlen MC et al. The complete genomes of Lactobacillus plantarum and Lactobacillus johnsonii reveal extensive differences in chromosome organization and gene content. Microbiology150(Pt 11), 3601–3611 (2004).
   PubMed Web of Science ®Google Scholar
• Altermann E, Russell WM, Azcarate-Peril MA et al. Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM. Proceedings of the National Academy of Sciences of the United States of America.102(11), 3906–3912 (2005).
   PubMed Web of Science ®Google Scholar
• Scheppler L, Vogel M, Zuercher AW et al. Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle. Vaccine20(23–24), 2913–2920 (2002).
   PubMed Web of Science ®Google Scholar
• Kruger C, Hu Y, Pan Q et al. In situ delivery of passive immunity by lactobacilli producing single-chain antibodies. Nat. Biotechnol.20(7), 702–706 (2002).
   PubMed Web of Science ®Google Scholar
• Steidler L, Hans W, Schotte L et al. Treatment of murine colitis by Lactococcus lactis secreting interleukin-10. Science289(5483), 1352–1355 (2000).
   PubMed Web of Science ®Google Scholar
• Chang TL, Chang CH, Simpson DA et al. Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4. Proc. Natl Acad. Sci. USA100(20), 11672–11677 (2003).
   PubMed Web of Science ®Google Scholar
• Salminen MK, Rautelin H, Tynkkynen S et al. Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin. Infect. Dis.38(1), 62–69 (2004).
   PubMed Web of Science ®Google Scholar
• Ouwehand AC, Saxelin M, Salminen S. Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood. Clin. Infect. Dis.39, 1858–1860 (2004).
   PubMed Web of Science ®Google Scholar
• Husni RN, Gordon SM, Washington JA, Longworth DL. Lactobacillus bacteremia and endocarditis: review of 45 cases. Clin. Infect. Dis.25(5), 1048–1055 (1997).
   PubMed Web of Science ®Google Scholar
• Horwitch CA, Furseth HA, Larson AM, Jones TL, Olliffe JF, Spach DH. Lactobacillemia in three patients with AIDS. Clin. Infect. Dis.21(6), 1460–1462 (1995).
   PubMed Web of Science ®Google Scholar
• Bayer AS, Chow AW, Betts D, Guze LB. Lactobacillemia – report of nine cases. Important clinical and therapeutic considerations. Am. J. Med.64(5), 808–813 (1978).
   PubMed Web of Science ®Google Scholar
• Rautio M, Jousimies-Somer H, Kauma H et al. Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG. Clin. Infect. Dis.28(5), 1159–1160 (1999).
   PubMed Web of Science ®Google Scholar
• MacKay AD, Taylor MB, Kibbler CC, Hamilton-Miller JM. Lactobacillus endocarditis caused by a probiotic organism. Clin. Microbiol. Infect.5(5), 290–292 (1999).
   PubMedGoogle Scholar
• Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, Shetty AK. Lactobacillus sepsis associated with probiotic therapy. Pediatrics115(1), 178–181 (2005).
   PubMed Web of Science ®Google Scholar
• De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr. Infect. Dis. J.24(3), 278–280 (2005).
   PubMed Web of Science ®Google Scholar
• Rao DR, Pulusani SR, Chawan CB. Role of fermented milk products in milk intolerance and other clinical conditions. Adv. Nutr. Res.7, 203–219 (1985).
   PubMedGoogle Scholar
• Alm L. Effect of fermentation on lactose, glucose, and galactose content in milk and suitability of fermented milk products for lactose intolerant individuals. J. Dairy Sci.65(3), 346–352 (1982).
   PubMed Web of Science ®Google Scholar
• Kim HS, Gilliland SE. Lactobacillus acidophilus as a dietary adjunct for milk to aid lactose digestion in humans. J. Dairy Sci.66, 959–966 (1983).
   PubMed Web of Science ®Google Scholar
• Fonden R, Mogensen G, Tanaka R, Salminen S. Culture-containing dairy products – effect in intestinal microflora, human nutrition and health – current knowledge and future perspectives. Bulletin352 (2000).
   Google Scholar
• Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig. Dis. Sci.47(11), 2625–2634 (2002).
   PubMed Web of Science ®Google Scholar
• Van Niel CW, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics109(4), 678–684 (2002).
   PubMed Web of Science ®Google Scholar
• Szajewska H, Mrukowicz JZ. Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials. J. Pediatr. Gastroenterol. Nutr.33(Suppl. 2), S17–S25 (2001).
   PubMed Web of Science ®Google Scholar
• Allen SJ, Okoko B, Martinez E, Gregorio G, Dans LF. Probiotics for treating infectious diarrhoea. Cochrane Database Syst. Rev.1 (2005).
   Google Scholar
• Guandalini S, Pensabene L, Zikri MA et al. Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial. J. Pediatr. Gastroenterol. Nutr.30(1), 54–60 (2000).
   PubMed Web of Science ®Google Scholar
• Shornikova AV, Casas IA, Mykkanen H, Salo E, Vesikari T. Bacteriotherapy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J.16(12), 1103–1107 (1997).
   PubMed Web of Science ®Google Scholar
• Shornikova AV, Casas IA, Isolauri E, Mykkanen H, Vesikari T. Lactobacillus reuteri as a therapeutic agent in acute diarrhea in young children. J. Pediatr. Gastroenterol. Nutr.24(4), 399–404 (1997).
   PubMed Web of Science ®Google Scholar
• Szajewska H, Kotowska M, Mrukowicz JZ, Armanska M, Mikolajczyk W. Efficacy of Lactobacillus GG in prevention of nosocomial diarrhea in infants. J. Pediatr.138(3), 361–365 (2001).
   PubMed Web of Science ®Google Scholar
• Mastretta E, Longo P, Laccisaglia A et al. Effect of Lactobacillus GG and breast-feeding in the prevention of rotavirus nosocomial infection. J. Pediatr. Gastroenterol. Nutr.35(4), 527–531 (2002).
   PubMed Web of Science ®Google Scholar
• Cremonini F, Di Caro S, Nista EC et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther.16(8), 1461–1467 (2002).
   PubMed Web of Science ®Google Scholar
• D’Souza AL, Rajkumar C, Cooke J, Bulpitt CJ. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Br. Med. J.324(7350), 1361 (2002).
   PubMed Web of Science ®Google Scholar
• Tursi A, Brandimarte G, Giorgetti GM, Modeo ME. Effect of Lactobacillus casei supplementation on the effectiveness and tolerability of a new second-line 10-day quadruple therapy after failure of a first attempt to cure Helicobacter pylori infection. Med. Sci. Monit.10(12), CR662–CR666 (2004).
   PubMed Web of Science ®Google Scholar
• Armuzzi A, Cremonini F, Ojetti V et al. Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study. Digestion63(1), 1–7 (2001).
   PubMed Web of Science ®Google Scholar
• Armuzzi A, Cremonini F, Bartolozzi F et al. The effect of oral administration of Lactobacillus GG on antibiotic-associated gastrointestinal side-effects during Helicobacter pylori eradication therapy. Aliment. Pharmacol. Ther.15(2), 163–169 (2001).
   PubMed Web of Science ®Google Scholar
• Cremonini F, Di Caro S, Covino M et al. Effect of different probiotic preparations on anti-Helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study. Am. J. Gastroenterol.97(11), 2744–2749 (2002).
   PubMed Web of Science ®Google Scholar
• Kalliomaki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet357(9262), 1076–1079 (2001).
   PubMed Web of Science ®Google Scholar
• Rautava S, Kalliomaki M, Isolauri E. Probiotics during pregnancy and breast-feeding might confer immunomodulatory protection against atopic disease in the infant. J. Allergy Clin. Immunol.109(1), 119–121 (2002).
   PubMed Web of Science ®Google Scholar
• Kalliomaki M, Salminen S, Poussa T, Arvilommi H, Isolauri E. Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet361(9372), 1869–1871 (2003).
   PubMed Web of Science ®Google Scholar
• Isolauri E, Arvola T, Sutas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin. Exp. Allergy30(11), 1604–1610 (2000).
   PubMed Web of Science ®Google Scholar
• Viljanen M, Kuitunen M, Haahtela T, Juntunen-Backman K, Korpela R, Savilahti E. Probiotic effects on faecal inflammatory markers and on faecal IgA in food allergic atopic eczema/dermatitis syndrome infants. Pediatr. Allergy Immunol.16(1), 65–71 (2005).
   PubMed Web of Science ®Google Scholar
• Pohjavuori E, Viljanen M, Korpela R et al. Lactobacillus GG effect in increasing IFN-gamma production in infants with cow’s milk allergy. J. Allergy Clin. Immunol.114(1), 131–136 (2004).
   PubMed Web of Science ®Google Scholar
• Gorbach SL. Traveler’s diarrhea. In: Infectious Diseases. Third Edition.Gorbach SL, Bartlett JG, Blacklow NR (Eds), Lippincott Williams & Wilkins, PA, USA, 681–688 (2004).
   Google Scholar
• Oksanen PJ, Salminen S, Saxelin M et al. Prevention of travellers’ diarrhoea by Lactobacillus GG. Ann. Med.22(1), 53–56 (1990).
   PubMed Web of Science ®Google Scholar
• Hilton E, Kolakowski P, Singer C, Smith M. Efficacy of Lactobacillus GG as a diarrheal preventive in travelers. J. Travel Med.4(1), 41–43 (1997).
   PubMedGoogle Scholar
• Katelaris PH, Salam I, Farthing MJ. Lactobacilli to prevent traveler’s diarrhea? N. Engl. J. Med.333(20), 1360–1361 (1995).
   PubMed Web of Science ®Google Scholar
• dios Pozo-Olano J, Warram JH Jr, Gomez RG, Cavazos MG. Effect of a lactobacilli preparation on traveler’s diarrhea. A randomized, double blind clinical trial. Gastroenterology74(5 Pt 1), 829–830 (1978).
   PubMed Web of Science ®Google Scholar
• Hatakka K, Savilahti E, Ponka A et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. Br. Med. J.322(7298), 1327 (2001).
   PubMed Web of Science ®Google Scholar
• Weizman Z, Asli G, Alsheikh A. Effect of a probiotic infant formula on infections in child care centers: comparison of two probiotic agents. Pediatrics115(1), 5–9 (2005).
   PubMed Web of Science ®Google Scholar
• Meurman JH, Antila H, Salminen S. Recovery of Lactobacillus strain GG (ATCC 53103) from saliva of healthy volunteers after consumption of yoghurt prepared with the bacterium. Microb. Ecol. Health Dis.7, 295–298 (1994).
   Web of Science ®Google Scholar
• Nase L, Hatakka K, Savilahti E et al. Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res.35(6), 412–420 (2001).
   PubMed Web of Science ®Google Scholar
• Gluck U, Gebbers JO. Ingested probiotics reduce nasal colonization with pathogenic bacteria (Staphylococcus aureus, Streptococcus pneumoniae, and beta-hemolytic streptococci). Am. J. Clin. Nutr.77, 517–520 (2003).
   PubMed Web of Science ®Google Scholar
• Coconnier MH, Lievin V, Hemery E, Servin AL. Antagonistic activity against Helicobacter infection in vitro and in vivo by the human Lactobacillus acidophilus strain LB. Appl. Environ. Microbiol.64(11), 4573–4580 (1998).
   PubMed Web of Science ®Google Scholar
• Midolo PD, Lambert JR, Hull R, Luo F, Grayson ML. In vitro inhibition of Helicobacter pylori NCTC 11637 by organic acids and lactic acid bacteria. J. Appl. Bacteriol.79(4), 475–479 (1995).
   PubMedGoogle Scholar
• Aiba Y, Suzuki N, Kabir AM, Takagi A, Koga Y. Lactic acid-mediated suppression of Helicobacter pylori by the oral administration of Lactobacillus salivarius as a probiotic in a gnotobiotic murine model. Am. J. Gastroenterol.93(11), 2097–2101 (1998).
   PubMed Web of Science ®Google Scholar
• Kabir AM, Aiba Y, Takagi A, Kamiya S, Miwa T, Koga Y. Prevention of Helicobacter pylori infection by lactobacilli in a gnotobiotic murine model. Gut41(1), 49–55 (1997).
   PubMed Web of Science ®Google Scholar
• Wang KY, Li SN, Liu CS et al. Effects of ingesting Lactobacillus- and Bifidobacterium-containing yogurt in subjects with colonized Helicobacter pylori. Am. J. Clin. Nutr.80(3), 737–741 (2004).
   PubMed Web of Science ®Google Scholar
• Gotteland M, Cruchet S, Brunser O. Can the amount of Helicobacter pylori in the stomach be kept low through probiotic intake? Am. J. Clin. Nutr.81(4), 939 (2005).
   PubMedGoogle Scholar
• Michetti P, Dorta G, Wiesel PH et al. Effect of whey-based culture supernatant of Lactobacillus acidophilus (johnsonii) La1 on Helicobacter pylori infection in humans. Digestion60(3), 203–209 (1999).
   PubMed Web of Science ®Google Scholar
• Sakamoto I, Igarashi M, Kimura K, Takagi A, Miwa T, Koga Y. Suppressive effect of Lactobacillus gasseri OLL 2716 (LG21) on Helicobacter pylori infection in humans. J. Antimicrob. Chemother.47(5), 709–710 (2001).
   PubMed Web of Science ®Google Scholar
• Burke DA, Axon AT. Ulcerative colitis and Escherichia coli with adhesive properties. J. Clin. Pathol.40(7), 782–786 (1987).
   PubMed Web of Science ®Google Scholar
• Favier C, Neut C, Mizon C, Cortot A, Colombel JF, Mizon J. Fecal beta-d-galactosidase production and bifidobacteria are decreased in Crohn’s disease. Dig. Dis. Sci.42(4), 817–822 (1997).
   PubMed Web of Science ®Google Scholar
• Bruzzese E, Raia V, Gaudiello G et al. Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment. Pharmacol. Ther.7, 813–819 (2004).
   Google Scholar
• Biller JA, Katz AJ, Flores AF, Buie TM, Gorbach SL. Treatment of recurrent Clostridium difficile colitis with Lactobacillus GG. J. Pediatr. Gastroenterol. Nutr.21(2), 224–226 (1995).
   PubMed Web of Science ®Google Scholar
• Gorbach SL, Chang TW, Goldin B. Successful treatment of relapsing Clostridium difficile colitis with Lactobacillus GG. Lancet2(8574), 1519 (1987).
   PubMed Web of Science ®Google Scholar
• Bennett RG, Gorbach SL, Goldin BR et al. Treatment of relapsing Clostridium difficile diarrhea with Lactobacillus GG. Nutr. Today31(6), 35S–38S (1996).
   Google Scholar
• Plummer S, Weaver MA, Harris JC, Dee P, Hunter J. Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int. Microbiol.7(1), 59–62 (2004).
   PubMed Web of Science ®Google Scholar
• Lin HC, Su BH, Chen AC et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics115(1), 1–4 (2005).
   PubMed Web of Science ®Google Scholar
• Mertz HR. Irritable bowel syndrome. N. Engl. J. Med.349(22), 2136–2146 (2003).
   PubMed Web of Science ®Google Scholar
• Chadwick VS, Chen W, Shu D et al. Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology122(7), 1778–1783 (2002).
   PubMed Web of Science ®Google Scholar
• Gonsalkorale WM, Perrey C, Pravica V, Whorwell PJ, Hutchinson IV. Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? Gut52(1), 91–93 (2003).
   PubMed Web of Science ®Google Scholar
• Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica5(3), 185–194 (1982).
   PubMed Web of Science ®Google Scholar
• Baharav E, Mor F, Halpern M, Weinberger A. Lactobacillus GG bacteria ameliorate arthritis in Lewis rats. J. Nutr.134(8), 1964–1969 (2004).
   PubMed Web of Science ®Google Scholar
• Hatakka K, Martio J, Korpela M et al. Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis – a pilot study. Scand. J. Rheumatol.32(4), 211–215 (2003).
   PubMed Web of Science ®Google Scholar
• Commane DM, Shortt CT, Silvi S, Cresci A, Hughes RM, Rowland IR. Effects of fermentation products of pro- and prebiotics on trans-epithelial electrical resistance in an in vitro model of the colon. Nutr. Cancer51(1), 102–109 (2005).
   PubMed Web of Science ®Google Scholar
• Pool-Zobel BL, Neudecker C, Domizlaff I et al. Lactobacillus- and Bifidobacterium-mediated antigenotoxicity in the colon of rats. Nutr. Cancer26(3), 365–380 (1996).
   PubMed Web of Science ®Google Scholar
• McIntosh GH, Royle PJ, Playne MJ. A probiotic strain of L. acidophilus reduces DMH-induced large intestinal tumors in male Sprague-Dawley rats. Nutr. Cancer35(2), 153–159 (1999).
   PubMed Web of Science ®Google Scholar
• Rowland I. Probiotics and colorectal cancer risk. Br. J. Nutr.91(6), 805–807 (2004).
   PubMed Web of Science ®Google Scholar
• Oberreuther-Moschner DL, Jahreis G, Rechkemmer G, Pool-Zobel BL. Dietary intervention with the probiotics Lactobacillus acidophilus 145 and Bifidobacterium longum 913 modulates the potential of human faecal water to induce damage in HT29clone19A cells. Br. J. Nutr.91(6), 925–932 (2004).
   PubMed Web of Science ®Google Scholar
• Cooke KR, Olkiewicz K, Erickson N, Ferrara JL. The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease. J. Endotoxin Res.8(6), 441–448 (2002).
   PubMedGoogle Scholar
• Beelen DW, Elmaagacli A, Muller KD, Hirche H, Schaefer UW. Influence of intestinal bacterial decontamination using metronidazole and ciprofloxacin or ciprofloxacin alone on the development of acute graft-versus-host disease after marrow transplantation in patients with hematologic malignancies: final results and long-term follow-up of an open-label prospective randomized trial. Blood93(10), 3267–3275 (1999).
   PubMed Web of Science ®Google Scholar
• Gerbitz A, Schultz M, Wilke A et al. Probiotic effects on experimental graft-versus-host disease: let them eat yogurt. Blood103(11), 4365–4367 (2004).
   PubMed Web of Science ®Google Scholar
• Kruis W, Fric P, Pokrotnieks J et al. Maintaining remission of ulcerative colitis with the probiotics Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut53(11), 1617–1623 (2004).
   PubMed Web of Science ®Google Scholar
• Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet354(9179), 635–639 (1999).
   PubMed Web of Science ®Google Scholar
• Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria-fermented milk on ulcerative colitis. J. Am. Coll. Nutr.22(1), 56–63 (2003).
   PubMed Web of Science ®Google Scholar
• Malchow HA. Crohn’s disease and Escherichia coli. A new approach in therapy to maintain remission of colonic Crohn’s disease? J. Clin. Gastroenterol.25(4), 653–658 (1997).
   PubMed Web of Science ®Google Scholar
• Prantera C, Scribano ML, Falasco G, Andreoli A, Luzi C. Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn’s disease: a randomised controlled trial with Lactobacillus GG. Gut51(3), 405–409 (2002).
   PubMed Web of Science ®Google Scholar
• Laake KO, Line PD, Grzyb K et al. Assessment of mucosal inflammation and blood flow in response to four weeks’ intervention with probiotics in patients operated with a J-configurated ileal-pouch-anal-anastomosis (IPAA). Scand. J. Gastroenterol.39(12), 1228–1235 (2004).
   PubMed Web of Science ®Google Scholar
• Laake KO, Bjorneklett A, Aamodt G et al. Outcome of four weeks’ intervention with probiotics on symptoms and endoscopic appearance after surgical reconstruction with a J-configurated ileal-pouch-anal-anastomosis in ulcerative colitis. Scand. J. Gastroenterol.40(1), 43–51 (2005).
   PubMed Web of Science ®Google Scholar
• Gionchetti P, Rizzello F, Helwig U et al. Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology124(5), 1202–1209 (2003).
   PubMed Web of Science ®Google Scholar
• Mimura T, Rizzello F, Helwig U et al. Once daily high dose probiotic therapy (VSL3) for maintaining remission in recurrent or refractory pouchitis. Gut53(1), 108–114 (2004).
   PubMed Web of Science ®Google Scholar
• Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME. Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am. J. Gastroenterol.91(8), 1579–1585 (1996).
   PubMed Web of Science ®Google Scholar
• Hunter JO, Lee AJ, King TS, Barratt MEJ, Linggoodd MA, Blades JA. Enterococcus faecium strain PR88: an effective probiotic. Gut38(Suppl. 1), A62 (1996).
   Google Scholar
• Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B. Alteration of intestinal microflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am. J. Gastroenterol.95(5), 1231–1238 (2000).
   PubMed Web of Science ®Google Scholar
• Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig. Dis. Sci.47(11), 2615–2620 (2002).
   PubMed Web of Science ®Google Scholar
• Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur. J. Gastroenterol. Hepatol.13(10), 1143–1147 (2001).
   PubMed Web of Science ®Google Scholar
• Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res. Microbiol.152(8), 735–741 (2001).
   PubMed Web of Science ®Google Scholar
• Bazzocchi G, Gionchetti P, Almerigi PF, Amadini C, Campieri M. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. Dig. Liver Dis.34(Suppl. 2), S48–S53 (2002).
   PubMedGoogle Scholar
• Kim HJ, Camilleri M, McKinzie S et al. A randomized controlled trial of a probiotic, VSL3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment. Pharmacol. Ther.17(7), 895–904 (2003).
   PubMed Web of Science ®Google Scholar
• O’Sullivan MA, O’Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig. Liver Dis.32(4), 294–301 (2000).
   PubMedGoogle Scholar
• O’Mahony L, McCarthy J, Kelly P et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology128(3), 541–551 (2005).
   PubMed Web of Science ®Google Scholar